Finley John David 4
4 · PALISADE BIO, INC. · Filed May 22, 2024
Insider Transaction Report
Form 4
Finley John David
DirectorCEO, CFO
Transactions
- Award
Common Stock, par value $0.01
2024-05-20$4.97/sh+666$3,312→ 7,437 total
Holdings
- 51(indirect: By LLC)
Common Stock, par value $0.01
Footnotes (2)
- [F1]Shares were purchased pursuant to the Palisade Bio, Inc. 2021 Employee Stock Purchase Plan, as amended ("ESPP") for the ESPP purchase period from November 21, 2023 through May 20, 2024. In accordance with the ESPP, the shares were purchased in a transaction exempt under Rule 16b-3(c) at a price equal to 85% of the closing price of the issuer's common stock on May 20, 2024.
- [F2]Reporting Person is the managing member of FCW Investments LLC and has the sole investment and voting power over the securities held by this entity.